P0828 - Adjuvant vs. progression-triggered treatment with gemcitabine after radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (AUO-AB 22-00): Long-term follow-up of a randomized multicenter phase 3 trial

F-C Von Rundstedt,M Stöckle,R Hofmann,E Becht,M Müller,M Kühn,P Albers,J Heinzelbecker,N Spieler,A Bannowsky,S Langbein,J Kamradt,B Volkmer,C Fischer,G Steiner,H.M Weber,S Wellek,J Lehmann,M Retz

doi:10.1016/s0302-2838(21)01203-3

P0828 - Adjuvant vs. progression-triggered treatment with gemcitabine after radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (AUO-AB 22-00): Long-term follow-up of a randomized multicenter phase 3 trial

F-C Von Rundstedt, M Stöckle + Show 17 more

https://doi.org/10.1016/s0302-2838(21)01203-3

Copy DOI

Journal: European Urology

Publication Date: Jun 1, 2021

#Radical Cystectomy #Adjuvant Treatment + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

P0828 - Adjuvant vs. progression-triggered treatment with gemcitabine after radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (AUO-AB 22-00): Long-term follow-up of a randomized multicenter phase 3 trial

Full Text